KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 163 filers reported holding KARUNA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,800,946 | -53.2% | 117,103 | -39.9% | 0.01% | -57.1% |
| Q2 2023 | $42,280,979 | +1467480.0% | 194,978 | +1230.0% | 0.02% | +950.0% |
| Q4 2022 | $2,881 | -100.0% | 14,660 | -73.7% | 0.00% | -71.4% |
| Q3 2022 | $12,548,000 | +88.3% | 55,787 | +5.9% | 0.01% | +40.0% |
| Q2 2022 | $6,665,000 | +1214.6% | 52,679 | +1217.3% | 0.01% | – |
| Q1 2022 | $507,000 | -64.0% | 3,999 | -62.9% | 0.00% | -100.0% |
| Q4 2021 | $1,410,000 | -48.4% | 10,766 | -51.8% | 0.00% | -50.0% |
| Q3 2021 | $2,734,000 | +197.8% | 22,348 | +192.6% | 0.00% | – |
| Q1 2021 | $918,000 | -84.1% | 7,637 | -86.6% | 0.00% | -100.0% |
| Q4 2020 | $5,771,000 | +62.7% | 56,807 | +23.8% | 0.00% | 0.0% |
| Q3 2020 | $3,547,000 | +174.3% | 45,872 | +295.6% | 0.00% | +100.0% |
| Q2 2020 | $1,293,000 | +112.0% | 11,597 | -69.0% | 0.00% | +100.0% |
| Q3 2019 | $610,000 | -57.1% | 37,398 | -47.3% | 0.00% | -50.0% |
| Q2 2019 | $1,421,000 | – | 70,968 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,952,441 | $150,963,000 | 11.19% |
| Eventide Asset Management | 901,077 | $69,671,000 | 1.36% |
| First Light Asset Management, LLC | 128,200 | $9,912,000 | 1.02% |
| Prosight Management, LP | 15,826 | $1,224,000 | 0.58% |
| MOODY ALDRICH PARTNERS LLC | 30,970 | $2,395,000 | 0.50% |
| PFM Health Sciences, LP | 137,960 | $10,667,000 | 0.49% |
| Rock Springs Capital Management LP | 244,106 | $18,874,000 | 0.48% |
| Atika Capital Management LLC | 73,500 | $5,683,000 | 0.46% |
| Hood River Capital Management LLC | 132,400 | $10,237,000 | 0.44% |
| CATALYST PRIVATE WEALTH, LLC | 5,006 | $387,000 | 0.38% |